GenMont Biotech Incorporation (TPE:3164)

Market Cap	1.54B -17.8%
Revenue (ttm)	401.23M +4.1%
Net Income	57.20M -0.1%
EPS	0.66
Shares Out	86.01M
PE Ratio	27.20
Forward PE	n/a
Dividend	0.80 (4.46%)
Ex-Dividend Date	Apr 8, 2026

Volume	1,430
Average Volume	56,915
Open	18.00
Previous Close	17.95
Day's Range	17.90 - 18.10
52-Week Range	17.20 - 22.40
Beta	0.15
RSI	46.39
Earnings Date	May 8, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3164

Financial Performance

In 2025, TPE:3164's revenue was 401.23 million, an increase of 4.11% compared to the previous year's 385.37 million. Earnings were 57.20 million, a decrease of -0.09%.